Embryonic stem cells |
The immense potential of differentiation into any of the cell types |
Potential risk of tumour formation and ethical arguments |
[1, 60–63, 68, 69, 82–85, 150, 162] |
Driving ganglion and amacrine cells from hESCs by using a combination of noggin, dkk1 and IGF-1 [157]; the differentiation mouse and hESCs into RGCs [158]; the differentiation of hESCs and iPSC cells into functional RGCs by applying a stepwise chemical protocol [159] |
Induced pluripotent stem cells |
The immense potential of differentiation into any of the cell types, no risk of immune rejection; can be directly generated from any adult tissue |
Tumorigenic contamination; possible immunogenicity; ethical issues |
[45, 71, 72, 74, 88, 89, 100] |
The presence of retina ganglion precursor by a synthetic xeno-free culture substrate for iPSCs induction [160]; the development of RGCs and photoreceptors precursors from mouse iPSCs [161] |
Adult stem/progenitor cells |
A promising resource for autologous transplant, avoiding tumorigenesis and immunosuppression |
Poor expansion, survival ability and functional (synaptic) integration of donor cells |
[56, 64–67, 70] |
Functional differentiation of RGCs from multipotent progenitor cells [162] |